| Luis | I do some voluntary work http://www.czwg.com/rx-abilify-drug.pdf passed is 20 mg of abilify a high dose kyrics chisel Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized cellular therapies to treat multiple sclerosis (MS) based on its proprietary T-cell technology. Its leading therapy candidate includes Tcelna, a novel T-cell immunotherapy, which is in Phase IIb clinical development for the treatment of patients with secondary progressive MS. |
|